Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes.

Sathyanarayana, Padma

Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes. [electronic resource] - Obesity (Silver Spring, Md.) Dec 2011 - 2310-5 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1930-739X

10.1038/oby.2011.152 doi


Adiponectin--blood
Adipose Tissue--drug effects
Alanine Transaminase--blood
Aspartate Aminotransferases--blood
Biomarkers--blood
Blood Glucose--metabolism
Body Mass Index
Body Weight--drug effects
Diabetes Mellitus, Type 2--diet therapy
Drug Therapy, Combination
Exenatide
Fasting
Fatty Acids, Nonesterified--blood
Glucagon-Like Peptide-1 Receptor
Glycated Hemoglobin--metabolism
Humans
Hypoglycemic Agents--pharmacology
Liver--drug effects
Magnetic Resonance Spectroscopy
Metformin--therapeutic use
Middle Aged
Obesity--complications
PPAR gamma--agonists
Peptides--pharmacology
Pioglitazone
Receptors, Glucagon--agonists
Thiazolidinediones--pharmacology
Triglycerides--blood
Venoms--pharmacology